Starting in October 2025, patients in the U.S. without insurance will be able to buy certain AstraZeneca drugs directly from […]

Lithuania, a country known for its love of basketball, is now making a name for itself in the life sciences

More than ten years ago, the first multispecific antibody drug entered the market. Now, these advanced treatments are gaining popularity

A recent TV ad for a heart medication showed a patient enjoying whale-watching, football games, and nature trips with his

Genetix Biotherapeutics, formerly known as Bluebird bio, has officially rebranded, marking a return to its original name from 1992 when

On September 12, the European Commission’s EU Data Act took effect, requiring many businesses in Europe to rethink how they

Drug developers worldwide have made exciting progress in treating narcolepsy by focusing on a key brain protein called orexin-2. This

In May, the oncology company BeOne Medicines, formerly known as BeiGene, relocated its headquarters from China to Basel, Switzerland. According

AstraZeneca’s drug Imfinzi (durvalumab) has been approved for use in England and Wales to treat adults with a specific type